For research use only. Not for therapeutic Use.
Luzindole (CAT: R000851) is a selective melatonin receptor antagonist with preferential activity toward MT₂ (Mel1b) over MT₁ (Mel1a) receptors, exhibiting Ki values of 10.2 nM and 158 nM, respectively. It is widely used in circadian rhythm, neuroimmunology, and mood regulation research. In vitro, Luzindole inhibits antigen-specific proliferation of MBP-reactive T cells, while in vivo it suppresses experimental autoimmune encephalomyelitis (EAE). Additionally, Luzindole shows antidepressant-like effects, reducing immobility time in behavioral assays in a dose- and time-dependent manner. These properties make Luzindole a valuable pharmacological tool for dissecting melatonin receptor signaling in neuroinflammation, depression, and circadian biology.
CAS Number | 117946-91-5 |
Synonyms | N-[2-(2-benzyl-1H-indol-3-yl)ethyl]acetamide |
Molecular Formula | C19H20N2O |
Purity | ≥95% |
IUPAC Name | N-[2-(2-benzyl-1H-indol-3-yl)ethyl]acetamide |
InChI | InChI=1S/C19H20N2O/c1-14(22)20-12-11-17-16-9-5-6-10-18(16)21-19(17)13-15-7-3-2-4-8-15/h2-10,21H,11-13H2,1H3,(H,20,22) |
InChIKey | WVVXBPKOIZGVNS-UHFFFAOYSA-N |
SMILES | CC(=O)NCCC1=C(NC2=CC=CC=C21)CC3=CC=CC=C3 |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |